Literature DB >> 16933097

A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures.

Chen Mao1, Sai Prasanth Chamarthy, Stephen R Byrn, Rodolfo Pinal.   

Abstract

PURPOSE: To present a calorimetry-based approach for estimating the initial (at the onset of annealing) relaxation time (tau (0)) of organic amorphous solids at relatively low temperatures, and to assess the temperature where molecular mobility of the amorphous drug is reduced to a level comparable with the desired shelf-life of the product.
MATERIALS AND METHODS: Values of tau (0) for six amorphous pharmaceutical compounds were estimated based on the nonlinear Adam-Gibbs equation. Fragility was determined from the scanning rate-dependence of the glass transition temperature (T (g)). The initial enthalpic and entropic fictive temperatures were obtained from the T (g) and the heat capacities (C (p)) of the amorphous and crystalline forms.
RESULTS: At a relatively low temperature ( approximately 40 degrees C or more below T (g)), tau (0) for the different compounds varies by over an order of magnitude. For some materials, the practical storage temperature at T (g) - 50 K was found to be still too high to ensure long-term stability. The estimated tau (0) is highly sensitive to the fragility of the material and the C (p) of the crystalline and amorphous forms. Materials with high fragility or greater C (p) differences between crystalline and amorphous forms tend to have longer tau (0).
CONCLUSIONS: The proposed method can be used to estimate molecular mobility at relatively low temperatures without having to conduct enthalpy recovery experiments. An accurate tau (0) determination from this method relies on faithful fragility measurements.

Mesh:

Year:  2006        PMID: 16933097     DOI: 10.1007/s11095-006-9071-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Interpretation of relaxation time constants for amorphous pharmaceutical systems.

Authors:  S L Shamblin; B C Hancock; Y Dupuis; M J Pikal
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

2.  Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.

Authors:  Y Aso; S Yoshioka; S Kojima
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

3.  Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs.

Authors:  I Weuts; D Kempen; K Six; J Peeters; G Verreck; M Brewster; G Van den Mooter
Journal:  Int J Pharm       Date:  2003-06-18       Impact factor: 5.875

4.  Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition.

Authors:  Joaquim J Moura Ramos; Raquel Taveira-Marques; Hermínio P Diogo
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

5.  Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.

Authors:  Chen Mao; Sai Prasanth Chamarthy; Rodolfo Pinal
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 6.  Chemical reactivity in solid-state pharmaceuticals: formulation implications.

Authors:  S R Byrn; W Xu; A W Newman
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

7.  The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 8.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

9.  Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin.

Authors:  Ping Tong; George Zografi
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  4 in total

Review 1.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

2.  Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation.

Authors:  Xin Feng; Xingyou Ye; Jun-Bom Park; Wenli Lu; Joe Morott; Brad Beissner; Zhuoyang John Lian; Elanor Pinto; Vivian Bi; Stu Porter; Tom Durig; Soumyajit Majumdar; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-07-21       Impact factor: 3.225

3.  The Role of Configurational Entropy in Amorphous Systems.

Authors:  Kirsten A Graeser; James E Patterson; J Axel Zeitler; Thomas Rades
Journal:  Pharmaceutics       Date:  2010-05-25       Impact factor: 6.321

Review 4.  Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.

Authors:  Kohsaku Kawakami
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.